Literature DB >> 29171989

Comparative analysis of immune function, hemorheological alterations and prognosis in colorectal cancer patients with different traditional Chinese medicine syndromes.

Cheng-Yang Wang1, Huan-Zhang Ding2, Xiao Tang2, Ze-Geng Li3.   

Abstract

OBJECTIVE: The present study investigates the differences in immune function, hemorheological alterations and prognostic evaluation in colorectal cancer (CRC) patients with different traditional Chinese medicine (TCM) syndromes.
METHODS: A total of 128 patients, diagnosed as stage II and III of CRC, were recruited. They were assigned into three TCM syndromes: deficiency syndrome, excess syndrome, and syndrome of intermingled deficiency and excess, and another 53 healthy individuals were selected as the control. Flow cytometry was used to determine the peripheral blood lymphocyte subsets (the levels of CD+3, CD+4, CD+8, NK cells, and the ratios of CD+4/CD+8, Th1/Th2 and Tc1/Tc2). Whole blood viscosity (WBV), plasma viscosity (PV), hematocrit (Hct), erythrocyte sedimentation rate (ESR), plasma fibrinogen concentration (PFC) were measured using a fully-automatic blood rheological instrument. The univariate analysis and Cox regression analysis were conducted to evaluate the prognosis of CRC patients with different TCM syndromes.
RESULTS: Compared with healthy individuals, CRC patients with three different syndromes had lower levels of CD+3, CD+4, NK cells, and ratios of CD+4/CD+8, Th1/Th2 and Tc1/Tc2, but higher level of CD+8, WBV, PV, Hct, ESR and PFC. Besides, patients with excess syndrome showed the highest levels of CD3+, CD4+ and NK cells, and ratios of CD+4/CD+8, Th1/Th2 and Tc1/Tc2, but the lowest level of CD+8 among three syndromes, and those with deficiency syndrome showed an opposite trend. Compared with patients with excess syndrome, those with deficiency syndrome showed decreased WBV, PV, Hct, ESR and PFC. The pathological type, surgical approach, tumor node metastasis (TNM) stage, liver metastasis, TCM treatment time and different TCM syndromes were independent factors of prognostic survival in CRC patients except perioperative blood transfusion volume.
CONCLUSIONS: Taken together, we conclude that patients with TCM deficiency syndrome has lower immune function and poorer prognosis while patients with TCM excess syndrome has higher immune function and better prognosis of CRC.

Entities:  

Keywords:  Colorectal cancer; hemorheological alteration; immune function; prognosis; traditional Chinese medicine syndrome

Mesh:

Year:  2018        PMID: 29171989     DOI: 10.3233/CBM-170805

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  6 in total

1.  Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progression.

Authors:  Ying-Yi Wang; Na Zhou; Hong-Sheng Liu; Xiao-Lei Gong; Rui Zhu; Xiao-Yuan Li; Zhao Sun; Xu-Hong Zong; Ning-Ning Li; Chang-Ting Meng; Chun-Mei Bai; Tai-Sheng Li
Journal:  Cancer Med       Date:  2020-05-27       Impact factor: 4.452

2.  Assessment of the targeted effect of Sijunzi decoction on the colorectal cancer microenvironment via the ESTIMATE algorithm.

Authors:  Jiaxin Du; Quyuan Tao; Ying Liu; Zhanming Huang; He Jin; Wenjia Lin; Xinying Huang; Jingyan Zeng; Yongchang Zhao; Lingyu Liu; Qian Xu; Xue Han; Lixia Chen; Xin-Lin Chen; Yi Wen
Journal:  PLoS One       Date:  2022-03-18       Impact factor: 3.240

3.  Astragalus mongholicus Bunge and Curcuma aromatica Salisb. inhibits liver metastasis of colon cancer by regulating EMT via the CXCL8/CXCR2 axis and PI3K/AKT/mTOR signaling pathway.

Authors:  Fuyan Liu; Yan Liang; Ruolan Sun; Weicheng Yang; Zhongqing Liang; Junfei Gu; Fan Zhao; Decai Tang
Journal:  Chin Med       Date:  2022-08-03       Impact factor: 4.546

4.  An exploratory study on TCM syndrome differentiation in preoperative patients with colorectal cancer assisted by laboratory indicators.

Authors:  Ya-Nan Wang; Min Zou; Dou Wang; Zhi-Kuan Zhang; Lian-Ping Qu; Jing Xu; Cai-Dong Shi; Feng Gao
Journal:  Heliyon       Date:  2022-08-14

5.  Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology.

Authors:  Zhulin Wu; Chunshan Wei; Lianan Wang; Li He
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-29       Impact factor: 2.629

6.  Mechanisms of Core Chinese Herbs against Colorectal Cancer: A Study Based on Data Mining and Network Pharmacology.

Authors:  Tong Lin; Caijun Liang; Wenya Peng; Yuqin Qiu; Lisheng Peng
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-27       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.